Cardiff, United Kingdom

Alison Binns

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The Science and Technology Facilities Council. Active years: 2016.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alison Binns

Introduction

Alison Binns is a notable inventor based in Cardiff, GB. She has made significant contributions to the field of retinal measurement technology. Her work is characterized by a commitment to advancing medical imaging techniques.

Latest Patents

Alison Binns holds a patent for an "Apparatus and method for retinal measurement." This invention includes a retinal densitometer that features an illumination unit for outputting bleaching illumination and reflectance illumination at various wavelengths. The device is designed to determine the reflectance of the eye and includes an imaging device that outputs image data corresponding to the eye's reflectance. The control unit manages the sequence of illumination and imaging, enhancing the accuracy of retinal measurements.

Career Highlights

Alison Binns is affiliated with the Science and Technology Facilities Council, where she applies her expertise in developing innovative technologies. Her work has been instrumental in improving the methods used for retinal analysis, which can have significant implications for eye health and medical diagnostics.

Collaborations

Alison has collaborated with esteemed colleagues such as Stephen Todd and David Atkinson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alison Binns is a pioneering inventor whose work in retinal measurement technology exemplifies the intersection of innovation and healthcare. Her contributions continue to influence the field and improve medical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…